About the Authors

Kathryn T. Whelan

Contributed equally to this work with: Kathryn T. Whelan, Ansar A. Pathan

Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Ansar A. Pathan

Contributed equally to this work with: Kathryn T. Whelan, Ansar A. Pathan

Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Clare R. Sander

Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Helen A. Fletcher

Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Ian Poulton

Affiliation Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

Nicola C. Alder

Affiliation Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom

Adrian V. S. Hill

Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Helen McShane

helen.mcshane@ndm.ox.ac.uk

Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Competing Interests

AAP, AVSH and HMcS are all co-inventors on a composition of matter patent for MVA85A and are shareholders in a Joint Venture established to develop this vaccine.

Author Contributions

Conceived and designed the experiments: KTW AVH HM. Performed the experiments: KTW AAP. Analyzed the data: KTW AAP HF NCA HM. Contributed reagents/materials/analysis tools: CRS HF IP. Wrote the paper: KTW HM.